Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangzheng Xiaoji Capsule is a traditional Chinese medicine (TCM) formulation developed for use as an adjuvant therapy in cancer treatment, particularly for primary liver cancer in patients unsuitable for surgery due to dual deficiency of the spleen and kidney with internal obstruction of stasis toxin. The capsule contains a blend of herbal ingredients including Astragalus Root, Glossy Privet Fruit, Ginseng, Zedoaria, Lucid Ganoderma (Reishi), Fiveleaf Gynostemma, Roasted Rhizoma Atractylodis Macrocephalae, Barbated Skullcap Herb, Spreading Hedyotis Herb, Poria Slices, Ground Beetle (Eupolyphaga), Chicken's Gizzard-membrane (Endothelium Corneum Gigeriae Galli), Indian mockstrawberry herb (Duchesnea indica), Bittersweet Herb (Solanum nigrum), Capillary Wormwood Herb (Artemisia capillaris), and Paniculate Swallowwort Root. \nThe mechanism of action is multi-faceted and includes fortifying the spleen and kidney function according to TCM theory; inhibiting tumor angiogenesis; suppressing tumor metastasis; modulating immune response; reducing toxicity from chemotherapy/radiotherapy on white blood cells and liver function; improving quality of life by alleviating symptoms such as poor appetite and fatigue. Clinical studies suggest it can reduce adverse effects associated with conventional cancer therapies[3][5][6][8]. \nYangzheng Xiaoji Capsule has been studied internationally—including research collaborations between Cardiff University in the UK and Yiling Pharmaceutical—demonstrating its potential to inhibit tumor metastasis[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yangzheng xiaoji capsule.